| Rheumatoid arthritis |
2.04 |
0.00e+0 |
78/93 (83.87%) |
CXCL8;ATP6V1D;CXCL1;...
|
| Steroid biosynthesis |
2.02 |
0.00e+0 |
19/20 (95%) |
MSMO1;TM7SF2;SC5D;...
|
| Viral protein interaction with cytokine and cytokine re... |
2.01 |
0.00e+0 |
84/100 (84%) |
CXCL8;CCL4;CXCL1;...
|
| IL-17 signaling pathway |
1.86 |
1.25e-2 |
84/94 (89.36%) |
CXCL8;S100A9;CXCL1;...
|
| Glyoxylate and dicarboxylate metabolism |
1.85 |
9.97e-3 |
23/30 (76.67%) |
ACAT2;PCCB;PCCA;...
|
| African trypanosomiasis |
1.81 |
1.33e-2 |
32/37 (86.49%) |
HBB;IDO1;MYD88;...
|
| Amoebiasis |
1.81 |
1.28e-2 |
99/102 (97.06%) |
CXCL8;CXCL1;CXCL3;...
|
| Influenza A |
1.80 |
1.25e-2 |
156/172 (90.7%) |
CXCL8;CXCL10;VDAC1;...
|
| Toll-like receptor signaling pathway |
1.72 |
2.88e-2 |
94/104 (90.38%) |
CXCL8;CCL4;CXCL10;...
|
| Propanoate metabolism |
1.70 |
3.79e-2 |
30/34 (88.24%) |
ACAT2;ECHS1;PCCB;...
|
| NF-kappa B signaling pathway |
1.70 |
3.90e-2 |
90/104 (86.54%) |
CXCL8;CCL4;CXCL1;...
|
| Transcriptional misregulation in cancer |
1.68 |
3.82e-2 |
158/192 (82.29%) |
CXCL8;PROM1;PPARG;...
|
| Staphylococcus aureus infection |
1.67 |
4.06e-2 |
72/95 (75.79%) |
KRT19;KRT23;KRT18;...
|
| Valine, leucine and isoleucine degradation |
1.65 |
4.84e-2 |
42/48 (87.5%) |
ACAA1;HMGCS1;ACAT2;...
|
| Cytosolic DNA-sensing pathway |
1.65 |
4.52e-2 |
52/63 (82.54%) |
CCL4;CXCL10;IL1B;...
|
| AGE-RAGE signaling pathway in diabetic complications |
1.65 |
4.67e-2 |
97/100 (97%) |
CXCL8;VEGFA;CDKN1B;...
|
| Malaria |
1.64 |
4.81e-2 |
44/50 (88%) |
CXCL8;HBB;HGF;...
|
| Glycosylphosphatidylinositol (GPI)-anchor biosynthesis |
1.64 |
4.54e-2 |
20/26 (76.92%) |
PIGK;GPAA1;MPPE1;...
|
| NOD-like receptor signaling pathway |
1.64 |
4.30e-2 |
145/181 (80.11%) |
CXCL8;CXCL1;VDAC1;...
|
| TNF signaling pathway |
1.63 |
4.34e-2 |
103/112 (91.96%) |
CXCL1;CXCL10;CXCL3;...
|
| Tryptophan metabolism |
1.62 |
4.27e-2 |
35/42 (83.33%) |
KYNU;DLST;ACAT2;...
|
| Steroid hormone biosynthesis |
-1.82 |
4.68e-2 |
43/61 (70.49%) |
CYP7A1;HSD17B8;UGT2A3;...
|
